• Dividend and Expense Review – March 2019 – Quarterly Dividends Grow

    Welcome to the first of four big quarterly dividend months. If you own ETFs or mutual funds, you’re familiar with these months. After all, most of those funds pay quarterly with March being that first big quarter of the year. That means a lot of the dividends you get are concentrated in these quarter ending months. I’m always eager to see these months as they’re a big driver of my overall dividend growth for the year. One of my goals for this year is dividend driven and so far I’m in a good spot to get there. However, it’s this quarterly dividend growth that will really determine what medal I’ll…

  • Dog talking through a phone, thoughts on the apple services event

    The Apple Services Event – TV+, A Credit Card and More!

    Apple services are the next big thing. At least, that’s what Apple wants shareholders to think. Their earnings calls go out of their way to talk about it in detail and Tim Cook has made it a primary focus of his future results. It does seem like a good business. There’s high growth and high margin and it has helped Apple results in recent years. The phone still sells a lot but Apple wanted to prove that they’re no longer a one trick pony. Services was their answer to the old “too reliant on iPhone” chestnut. As an Apple investor, I think they’ve done a decent job with that. Apple…

  • Healthcare stocks falling are offset by contributions in my March 2019 portfolio update

    Portfolio Review – March 2019 – Healthcare Stocks Fall

    [This March portfolio review about healthcare stocks may contain affiliate links for which I receive a commission at no cost to you. I only recommend products I use and trust.] Healthcare stocks were an ugly sector to be in this month. The reason? A bevy of democratic candidates talking up medicare for all. It’s easy to see why that would be bad for healthcare. After all, there’s a ton of parties making money from our current healthcare system. However, that may change if certain candidates have their way. Uncertainty is rarely good for stocks so we saw a big dip in a lot of big healthcare names this month. That…